Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
glaxosmithkline
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
2
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
translate bio
wisconsin blog main
wisconsin top stories
abbvie
advaxis
adverum biotechnologies
aimmune therapeutics
albert bourla
alder biopharmaceuticals
alexander hardy
alzheimer's disease
amgen
amicus therapeutics
andrew oxtoby
arvinas
What
bio
ceo
2
×
crispr
roundup
acquisitions
albert
big
biggest
bosley's
bosley’s
bourla
bridge
bucks
cas
company
crime
departure
drug
editas
exit
future
guiding
imports
katrine
maker
maps
measured
medicine
moves
patients
personnel
pfizer
pfizer’s
revenue
surprising
today
week
world’s
Language
unknown
Current search:
roche
×
ceo
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
